Lymphoma — Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
Citation(s)
Comparing Two Schedules of Rituximab Maintenance in Rituximab-Responding Patients With Untreated, Chemotherapy Resistant or Relapsed Follicular Lymphoma: A Randomized Phase III Trial